TSS
INM icon

Two Sigma Securities’s InMed Pharmaceuticals INM Stock Holding History

Two Sigma Securities’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.1K Buy
+18,718
New +$17.6K ﹤0.01% 1447
2024
Q2 		– Sell
-771
Closed -$5.61K – 3314
2024
Q1 		$5.61K Buy
771
+126
+20% +$926 ﹤0.01% 2826
2023
Q4 		$5.36K Buy
+645
New +$6.26K ﹤0.01% 2876
2022
Q2 		– Sell
-36
Closed -$17K – 2520
2022
Q1 		$17K Buy
+36
New +$18.9K ﹤0.01% 1996

Other funds holding INM

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Two Sigma Securities's INM Position: Q1 2026 in Review

Two Sigma Securities opened a new position in InMed Pharmaceuticals (INM) in Q1 2026: 18,718 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #1447 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in INM as recently as Q1 2024.

Two Sigma Securities first reported a position in INM in Q1 2022 and has held it in 4 quarters since. The position peaked at $17K in Q1 2022. 9 funds tracked by Wall St. Rank hold INM as of Q1 2026.

  • Two Sigma Securities held 18,718 shares of InMed Pharmaceuticals worth $12.1K as of Q1 2026.
  • InMed Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
  • InMed Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1447 holding.
  • Two Sigma Securities first reported a position in InMed Pharmaceuticals in Q1 2022 and has held it in 4 quarters since.
  • Two Sigma Securities's InMed Pharmaceuticals position peaked at $17K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.